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Introduction: Hemostasis during thyroidectomy is essential; however, the safest, most efﬁcient and cost-
effective way to achieve this is unclear. The aim of this study was to evaluate the outcome of total
thyroidectomy (TT) performed with combination of harmonic scalpel (HS) and Floseal.
Methods: Patients undergone TT were divided into two groups: HS þ Floseal and traditional hemostasis
groups. The primary endpoint was 24-h drain output and blood-loss requiring reintervention. Secondary
endpoints included surgery duration, postsurgical complications and hypocalcemia rates.
Results: Between September 2012 and January 2014, 165 patients were enrolled (100 to HS þ Floseal, 65
to standard hemostasis); 80.5% female; mean age 42.3 years. The 24-h drain output was lower in the
HS þ Floseal group compared with standard TT. HS þ Floseal also had a shorter mean surgery time
(p < 0.0001) vs standard TT. No differences in post-surgical complications and in hypocalcemiarates
between groups.
Conclusion: combination of Floseal plus the HS is effective and safe for TT and it provides a comple-
mentary hemostatic approach.
© 2014 Surgical Associates Ltd. Published by Elsevier Ltd. All rights reserved.1. Introduction
Total thyroidectomy (TT) is the preferred option for the man-
agement of benign multinodular goiter and the standard treatment
for cancer [1e4]. An accurate dissection and hemostasis is essential
in order to provide a clear surgical ﬁeld during TT, minimize the risk
of structural damage, prevent post-surgical hemorrhage and avoid
the need for surgical drains; however, the safest, most efﬁcient and
cost-effective way to achieve these goals is still under debate. Be-
sides the traditional surgical hemostatic techniques, different he-
mostatic approaches which further minimize the risk of bleeding
and complications during thyroidectomy have become available.
These include ultrasonic coagulation, bipolar coagulation and
modern topical hemostatic agents.giero).
by Elsevier Ltd. All rights reservedThe Harmonic Scalpel (HS), a device that uses ultrasonic coag-
ulation via high frequency mechanical vibration (in the range
55,500 Hz) to allow both a cutting and hemostatic effect simulta-
neously [5], has been shown to be an effective surgical device
which decreases operative time, complications and bleeding in a
variety of surgical procedures [6e14]. The hemostatic effect is
achieved via protein denaturation rather than heat used in elec-
trosurgical hemostatic devices, which uses a high electric current to
produce the heat required for the hemostatic effect [15].
Floseal Hemostatic Matrix (Floseal; Baxter Healthcare Corpora-
tion, USA), a gelatin-thrombin matrix topical hemostatic agent that
has been on the market in the US and in Europe since 1999 [16], is a
combination of bovine-derived cross-linked gelatin granules and
topical human thrombin. It has been proven to reduce blood loss in a
varietyof surgical procedures [17e26] including thyroid surgery [27].
The aim of this study was to evaluate the outcome of these two
hemostatic approaches in combination, with their different and
potentially complementary mechanisms, in patients undergoing
TT..
Table 1
Baseline characteristics/demographics and surgical parameters.
Characteristic/demographic HS þ Floseal TT (n ¼ 100) Standard TT (n ¼ 65)
Mean age, years 49.3 ± 12.2 48.7 ± 12.2
Range 30.1e71.8 23.2e69.4
Gender, n (%)
Male 28 (28) 15 (23)
Female 72 (72) 50 (77)
BMI, kg/m2 23.7 ± 2.8 23.4 ± 3.3
Pulse rate, bpm 73.0 ± 6.89 73.6 ± 7.75
BP, mmHg
Systolic 123.7 ± 10.7 125.0 ± 12.4
Diastolic 77.9 ± 6.6 78.8 ± 6.2
Thyroid disease, n (%)
Goiter 79 (79) 48 (73.9)
Hyperthyroid goiter 9 (9) 7 (10.7)
Carcinoma 12 (12) 10 (15.4)
Thyroid weight, g 32.8 ± 3.3 45.9 ± 27.3
All data is presented as mean ± standard deviation (SD) unless otherwise stated.
BMI, body mass index; BP, blood pressure; bpm, beats per minute; CS, clinically
signiﬁcant; ECG, electrocardiogram; HS, harmonic scalpel.
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2.1. Study design
This single-center, prospective study investigated the hemo-
stasis efﬁcacy and safety of Floseal þ HS (Harmonic Focus; Ethicon
Endo-Surgery, Norderstedt, Germany)in patients undergoing TT.
Two groups were assessed: patients receiving Floseal þ HS, and
patients receiving traditional hemostatic procedures alone (gauze,
ligature, electrocauterization) during TT.
The protocol was reviewed and approved by local Independent
Ethics Committee/Institutional Review Board. The study was con-
ducted in accordance with the Declaration of Helsinki and ac-
cording to local and regional ethical standards. Written informed
consent was obtained from all patients.
2.2. Patients
Patients were included if they were 18e70 years of age and
were planning to undergo total thyroidectomy due to thyroid dis-
ease. Patients were excluded from the study if they had diabetes,
chronic renal disease or other metabolic diseases, had received
previous neck irradiation or surgery, had cervico-mediastinal goi-
ters, required lymphadenectomy, had a planned video assisted
thyroidectomy (minimally invasive) or one lobe pathology where
only hemi-thyroidectomy was planned, had known coagulopathy,
had active or past history of malignant systemic disease, were
pregnant or lactating females, had a known allergy to the compo-
nents of Floseal, were known to abuse drug or alcohol, or were
receiving chronic cortisone or platelet inhibitors.
2.3. Treatments and surgical technique
Total thyroidectomy was performed using institutional guide-
lines by experienced surgeons [28,29]. A 4e6 cm Kocher incision
was made at the lower neck crease two ﬁngers above the supra-
sternal notch with a scalpel. Traditional hemostatic procedure was
performed as follows: after division of the platysma, the cervical
linea alba is opened without division of the strap muscles. The
thyroid lobe is dissected progressively from the strap muscles.
Thyroid vessels were ligated and divided, rotating the thyroid lobe
medially before dividing vessels in the ligament of Berry, super-
vising and saving the recurrent laryngeal nerve, and the thyroid
lobe is removed. The procedure was repeated for the contra lateral
lobe. After a check for hemostasis, a drain is placed in the thyroid
bed. The cervical linea alba and platysma are sutured with
absorbable sutures, and the skin is closed by an intracutaneous
running suture.
In patients undergoing TT with HS þ Floseal, dissection and
ligation of vascular pedicles was done using the HS, with surgical
hemostasis used if additional hemostasis was deemed necessary
and Floseal was used for bleeding not responding to surgical he-
mostasis, in particular in the Gruber and Sappey ligaments, avoid-
ing electrocautery injuries to recurrent nerves.
In all patients a suction surgical drain was placed for the ﬁrst
24 h, as part of this study, in order to better objectivize and quantify
blood loss, although some centers did not longer consider drainage
useful after thyroidectomy.
All patients received the same postoperative protocol. Surgical
drain was removed after 24 h; a neck ultrasonographic evaluation
was performed 48 h after surgery to verify the presence of seroma
or blood collections. All patients in the study were discharged on
postoperative day 3 (72 h after surgery) for better evaluation of the
postoperative course. The postoperative follow-up care included
indirect laryngoscopy to check vocal cord mobility. An indirectlaryngoscopy was performed on postoperative day 2 to assess
transitional or permanent paralysis of laryngeal nerve; in case of
incidence of dysphonic voice, laryngoscopy was also reconsidered
after 1 week and 3 months.
The serum calcium level also was measured for all patients at 6,
12, 24, 48 h. In case of symptomatic hypocalcemia, intravenous
calcium was administered; in asymptomatic hypocalcemic patient,
oral calcium was given.2.4. Study endpoints
The primary endpoint was the drain output (ml) after 24 hours
and the presence of a signiﬁcant blood loss (if patient needed to
return to OR). Secondary endpoints included presence of seroma,
the duration of surgery, post-surgical complications and post-
surgical serum calcium level.2.5. Statistical analysis
Qualitative and quantitative descriptive analyses were per-
formed for all the variables collected. Qualitative variables were
analyzed using frequencies and percentages. Quantitative variables
were studied through the mean, standard deviation (SD), median
and interquartile (IQR) range (25 percentile e 75 percentile).
Parametric (analysis of variance [ANOVA]) and nonparametric tests
(Wilcoxon) were used for comparisons of numerical variables. For
the primary endpoint a Bonferroni adjustment was performed to
account formultiplicity. Fisher’s exact test was used for comparison
of categorical variables. In all statistical hypotheses, the signiﬁcance
level was set at a¼ 0.05. All analyses were performedwith the SPSS
software version 17.0.3. Results
3.1. Baseline characteristics and patient disposition
Between September 2012 and January 2014, 165 patients were
enrolled (100 to HS þ Floseal, 65 to standard hemostasis). Of the
165 patients, 80.5% were female and the mean age was
42.3years.There were no meaningful differences between the two
treatment groups with respect to demographic or baseline char-
acteristics (Table 1). However, the type of thyroid disease in each
group varied slightly between the treatment groups.
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Surgery was uneventful in the majority of patients (Table 1).
Three patients standard TT had surgical complications, with one
patient having dystonia with a saturated O2 of 98%.Compared with
HS þ Floseal, fewer patients who received standard hemostasis
during surgery had a dry surgical ﬁeld at the end of surgery and
before placement of the drain according to the surgeon (100% vs
85.6%, p< 0.001). No other meaningful differences between the two
treatment groups with respect to surgery were reported.3.3. Efﬁcacy outcomes
Drain output over 24 h was signiﬁcantly lower in patients who
received during surgery .The mean of 24-h drain output was
48.1 ± 20.4 mL in HS þ Floseal group vs 97.9 ± 24.2 mL in standard
TTgroup (95% CI  63.5, 32.3; p < 0.0001) (Table 2).
Incidence of post-operative seroma was higher in standard he-
mostasis group.
There was a statistically difference in the length of surgery:
patients in the HSþ Floseal group had a shorter mean surgery time,
compared with standard hemostasis (p < 0.0001) (Table 2).
Only one patient in standard hemostasis group developed
temporary laryngeal nerve paralysis; however, this condition
resolved at the 3-month follow-up visit. Another patient who
received HSþ Floseal and one patient in standard hemostasis group
developed hypomobility of the right side. Again this was resolved at
the 3-month follow-up.
No signiﬁcant differences in the rates of hypocalcaemia (serum
calcium <8.0 mg/dL) were observed between treatment groups
(p ¼ 0.37). Laboratory hypocalcaemia was reported in 17.6% and
22.7% of patients in the HS þ Floseal and standard hemostasis
groups, respectively. Similar results for the rate of symptomatic
hypocalcaemia was also observed (p ¼ 0.52).4. Discussion
To our knowledge this is the ﬁrst study to investigate the he-
mostasis efﬁcacy and safety of HS þ Floseal in patients undergoing
TT. This study showed that the use of HS þ Floseal can reduce drain
output compared with the standard TT, avoiding post-operative
seroma incidence. Our results are similar to those investigating
Floseal þ HS in patients undergoing thyroidectomy or laparoscopic
transperitoneal partial nephrectomy [20]. Similarly, other studies
on patients undergoing thyroidectomy [8,30]or laparoscopic
transperitoneal partial nephrectomy show all procedures were
feasible, safe, successful and reproducible by surgeons used to
complex laparoscopic procedure.
In our study the latter model of HS, the Harmonic Focus, was
used. It has been shown that this device can reduce mean operative
time in a prospective randomized study that compared outcomes
using twomodels of HS: the Harmonic Focus (n¼ 45) and the olderTable 2
Secondary endpoints.
Outcome HS þ Floseal TT (n ¼ 100) Standard TT (n ¼ 65)
Drain output over 24 h, mL
Mean ± SD 48.1 ± 20.4 97.9 ± 24.2*
Length of surgery, min
Mean ± SD 53.97 ± 15.26 88.67 ± 26.27*
Hospital stay, days
Mean ± SD 2.46 ± 0.59 2.59 ± 0.57
*p < 0.001.
HS, harmonic scalpel; SD, standard deviation.Harmonic Ace (n ¼ 45) in patients undergoing thyroid surgery [31].
We found similar data regarding operative time, showing a
reduction in the duration of surgery, allowing a shorter anesthesia
and a possibility to save time for other surgery in a single center.
All of the surgeons who performed TT in this study were
considered experts, with over 100 previous thyroidectomies con-
ducted. The effect of a surgeons previous experience had been
investigated in a retrospective analysis which considered the effect
of the ‘learning curve’ in the use of the HS, by comparing outcomes
after total thyroidectomy in the 12 months prior to adoption of the
HS (2003; n ¼ 77) and in a period of12 months, 2 years after the HS
was adopted (2006; n ¼ 106). Results showed that, once past the
learning curve, the HS signiﬁcantly reduces operative time and
postoperative hypocalcaemia, and is as safe as conventional surgery
with regard to voice change and bleeding [32].These individual
studies showing beneﬁts with the HS are further supported by
three meta-analyses [9,33,34].
Cost-effectiveness of the HS over traditional methods has also
been demonstrated in an analysis of data from a randomized
controlled trial of 198 patients undergoing surgery with the ultra-
sound scalpel (n ¼ 96) or traditional surgical methods (n ¼ 102)
using a hospital, third party payer and societal perspectives [35].
The HS provided a shorter mean operation time (p < 0.001) and
greater improvements in quality of life (p ¼ 0.002) versus tradi-
tional methods and cost effectiveness was demonstrated from a
hospital perspective (saving V119/patient) and a societal perspec-
tive (lower medical and non-medical resource consumption during
the 3 months post discharge follow-up period), calculated as an
overall saving of V325.36/patient [35].
In our study, incidence of post-operative complications was low
in both groups, in particular for vocal cord palsy. Our ﬁndings are in
agreement with those reported in previous similar studies. The lack
of post-surgical complications including nerve injuries at the 3
months’ follow-up in any groups was expected due to the high level
of surgical expertise. However, substituting electric coagulation
near Gruber ligament with hemostasis provided by Floseal, could
lower incidence of accidental recurrent nerve lesions [36e39].
There were also no signiﬁcant differences between treatment
groups in the rate of hypocalcaemia. However, the ratewas lower in
the HS þ Floseal group versus standard TT (17.6% vs 22.7%,
respectively). This little difference can be explained by a diminished
parathyroid gland “stupor” from electrical spread using
HSþ Floseal. There were no unexpected results from this study and
our ﬁndings were compatible with recent Literature [40e42].
5. Conclusions
This study shows that using a combination of Floseal plus the HS
is effective and safe for TT. Mean surgery time can be reduced as
well as 24-h post-surgical drain output and seroma formation,
without any increased risk of post-surgical complications. We
believe that Floseal Hemostatic Matrix plus the HS could provide a
complementary hemostatic approach in patients undergoing total
thyroidectomy. Further research is required to investigate the cost-
effectiveness of this combined approach in patients undergoing
thyroidectomy compared with convention and other approaches.
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